• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

Recent Advances in the Study of N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine (CAS: 1256360-57-2) in Chemical Biology and Pharmaceutical Research

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine (CAS: 1256360-57-2) is a boronic acid derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique boronate ester functional group, has been explored for its role in drug discovery, particularly in the development of protease inhibitors and as a versatile intermediate in organic synthesis. Recent studies have highlighted its utility in targeted drug delivery systems and as a key component in the synthesis of novel therapeutic agents.

One of the most notable advancements in the study of this compound is its application in the development of boron-containing drugs. Boron-based compounds have emerged as a promising class of therapeutics due to their ability to form reversible covalent bonds with biological targets, such as enzymes and receptors. The boronate ester moiety in N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine enables it to interact with serine proteases, making it a potential candidate for the treatment of diseases such as cancer, inflammation, and infectious diseases. Recent preclinical studies have demonstrated its efficacy in inhibiting specific proteases involved in tumor progression and metastasis.

In addition to its therapeutic potential, this compound has also been investigated for its role in chemical biology as a probe for studying enzyme mechanisms. The boronate ester group can act as a transition state analog, providing insights into the catalytic mechanisms of enzymes. Researchers have utilized this property to design activity-based probes that can selectively label and monitor enzyme activity in complex biological systems. Such probes are invaluable tools for understanding disease mechanisms and identifying new drug targets.

Recent synthetic methodologies have further expanded the utility of N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine. Advances in boron chemistry have enabled the efficient incorporation of this compound into more complex molecular architectures, facilitating the development of new drug candidates with improved pharmacokinetic properties. For instance, its use in Suzuki-Miyaura cross-coupling reactions has allowed for the rapid assembly of diverse boronic acid derivatives, which are increasingly important in medicinal chemistry.

Despite these promising developments, challenges remain in the clinical translation of boron-containing compounds. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed to fully realize the therapeutic potential of N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine. Ongoing research is focused on optimizing the chemical properties of this compound to enhance its drug-like characteristics while minimizing adverse effects.

In conclusion, N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine (CAS: 1256360-57-2) represents a versatile and promising scaffold in chemical biology and pharmaceutical research. Its unique boronate ester functionality, combined with recent advancements in synthetic and medicinal chemistry, positions it as a valuable tool for drug discovery and biological research. Future studies will likely continue to explore its potential in addressing unmet medical needs and advancing our understanding of disease mechanisms.

• 1150271-53-6(2-(N-Benzylaminomethyl)phenylboronic Acid Pinacol Ester)
• 1150271-49-0(2-(Pyrrolidinomethyl)phenylboronic Acid Pinacol Ester)
• 1256360-61-8(N-(4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-)
• 1256360-60-7(2-(Cyclohexylaminomethyl)-5-fluorophenylboronic acid, pinacol ester)
• 1218791-16-2(2-(Ethylaminomethyl)phenylboronic acid, pinacol ester)
• 859833-22-0(1-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]piperidine)
• 1150271-52-5(2-(N-Cyclopropylaminomethyl)phenylboronic Acid Pinacol Ester)
• 1256359-08-6(2-(N-Butylaminomethyl)phenylboronic acid, pinacol ester)
• 1256360-56-1(N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-1-amine)
• 129636-11-9(N,N-dimethyl-1-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine)